Phuong-Thu T Pham1, Gerald S Lipshutz2, Phuong-Truc T Pham3, Joseph Kawahji1, Jennifer S Singer4, Phuong-Chi T Pham51Division of Nephrology, Department of Medicine, Kidney and Pancreas Transplant Program, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California; 2Kidney and Pancreas Transplant Micklem Compet
Abstract Cetuximab and panitumumab are monoclonal antibodies (mAbs) against epidermal growth factor receptor (EGFR) that are effective agents for metastatic colorectal cancer (mCRC).Cetuximab can prolong survival by 8.2 BOTANICAL CLEANSER months in RAS wild-type (WT) mCRC patients.Unfortunately, resistance to targeted therapy impairs clinical use a
An application oriented cross-layer multi-channel(AOCM)MAC protocol was proposed for VANET.The AOCM protocol could derive the optimal control channel(CCH)interval to ensure the timely CHONDROITIN SULFATE and reliable transmission of safety messages on the CCH,based on real-time statistics and prediction for different types of sages coming from uppe